Houshang Makipour, MD
Gastroenterology · Woodbridge, VANPI 1184624389
Payments from drug & device makers
Across 40 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$163
- Takeda Pharmaceuticals U.S.A., Inc.$137
- Braintree Laboratories, Inc.$72
- UCB, Inc.$69
- Pfizer$61
- Daiichi Sankyo Inc.$61
- plus $168 from 6 others
What the payments were for
- Consulting fees$233%
- Food & beverage$63687%
- Gifts$7210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $137 |
| Braintree Laboratories, Inc. | 1 | $72 |
| UCB, Inc. | 3 | $69 |
| Pfizer | 2 | $61 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Shionogi Inc | 2 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $35 |
| Johnson & Johnson | 1 | $26 |
| Gilead | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
How this compares
$731 in reported general payments places this provider in the 25th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 52 | $889 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 65 | $832 |
| Omeprazole | 47 | $703 |
| Famotidine | 42 | $520 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $195 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Woodbridge
- Kenneth JosovitzWoodbridge$108K
- Jack HuangWoodbridge$55K
- Larry ClarkLynchburg$8.5M
- Arun SanyalRichmond$5.5M
- Mitchell ShiffmanNewport News$4.7M
- Jasmohan BajajRichmond$4.4M
- Michael FuchsRichmond$1.9M
- Stephen CaldwellCharlottesville$1.8M
- Nirish ShahRoanoke$1.7M
- Michael RyanNorfolk$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.